The Birmingham Assay Office (BAO) has announced that its CEO and assay master, Stella Layton, is to leave the role at the end of March 2017.
The BAO also announced that Doug Henry, an experienced managing director who has been responsible for several of the organisation’s key projects over the past two years, is to be appointed as joint CEO to work alongside Stella Layton until a permanent appointment has been made.
Layton, who joined in 2014 and became the UK’s first female assay master, has overseen a number of key projects including the move from the office’s outdated premises that it had occupied since 1878 to a new purpose-built facility.
She has also steered the development of a further sub-office initiative for the BAO, which opened earlier this year in Mumbai, and has, in addition, implemented a change in its management programme.
Kate Hartigan, chairman of BAO, said that during her three years in the post, Stella had been a “committed, dynamic and extremely capable leader, guiding the office through a period of significant change”.
She said: “Stella has provided strong and decisive leadership at a critical time in the development of the assay office. Our staff have responded wholeheartedly to the changes, inspired by her leadership, and as a result we have a committed, flexible and confident workforce.
“We would like to record our appreciation of Stella’s hugely valuable contribution to the organisation and to wish her well not only for the remaining period of her time with us but also for her personal and professional success in the future.”
An announcement on a permanent appointment to succeed Layton is expected in the New Year. However, she will support the office’s continuing projects on an ad hoc basis following her departure, in order to “ensure continuity”.